[Nociception pain and autism].

Nociception, douleur et autisme.

Journal

Medecine sciences : M/S
ISSN: 1958-5381
Titre abrégé: Med Sci (Paris)
Pays: France
ID NLM: 8710980

Informations de publication

Date de publication:
Feb 2021
Historique:
entrez: 16 2 2021
pubmed: 17 2 2021
medline: 27 10 2021
Statut: ppublish

Résumé

Autistic subjects frequently display sensory anomalies. Those regarding nociception and its potential outcome, pain, are of crucial interest. Indeed, because of numerous comorbidities, autistic subjects are more often exposed to painful situation. Despite being often considered as less sensitive, experimental studies evaluating this point are failing to reach consensus. Using animal model can help reduce variability and bring, regarding autism, an overview of potential alterations of the nociceptive system at the cellular and molecular level. Nociception, douleur et autisme. Les sujets autistes présentent fréquemment des anomalies sensorielles. Celles concernant la nociception ainsi que sa potentielle résultante, la douleur, sont d’un intérêt capital. En effet, du fait de nombreuses comorbidités, les sujets autistes sont plus souvent exposés à des situations douloureuses que la population générale. Alors qu’ils sont souvent considérés comme moins sensibles, les études expérimentales sur ce point sont loin de faire consensus. Utiliser des modèles animaux pourrait permettre de s’affranchir de certaines sources de variabilité et d’apporter, dans le cadre de l’autisme, une vue d’ensemble des altérations potentielles du système nociceptif aux niveaux cellulaire et moléculaire.

Autres résumés

Type: Publisher (fre)
Nociception, douleur et autisme.

Identifiants

pubmed: 33591257
doi: 10.1051/medsci/2020280
pii: msc200168
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

141-151

Informations de copyright

© 2021 médecine/sciences – Inserm.

Références

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5), 5
Thye MD, Bednarz HM, Herringshaw AJ, et al. The impact of atypical sensory processing on social impairments in autism spectrum disorder. Dev Cogn Neurosci 2018 ; 29 : 151–167.
Moore DJ. Acute pain experience in individuals with autism spectrum disorders: a review. Autism 2015 ; 19 : 387–399.
Summers J, Shahrami A, Cali S, et al. Self-injury in autism spectrum disorder and intellectual disability: exploring the role of reactivity to pain and sensory input. Brain Sci 2017 ; 7 : 1–16.
Bourne S, Machado AG, Nagel SJ. Basic anatomy and physiology of pain pathways. Neurosurg Clin North Am 2014 ; 25 : 629–638.
Woolf CJ, Ma Q. Nociceptors-noxious stimulus detectors. Neuron 2007 ; 55 : 353–364.
Cordero-Erausquin M, Inquimbert P, Schlichter R, et al. Neuronal networks and nociceptive processing in the dorsal horn of the spinal cord. Neuroscience 2016 ; 338 : 230–247.
Millan MJ. Descending control of pain. Prog Neurobiol 2002 ; 66 : 355–474.
Garcia-Larrea L, Peyron R. Pain matrices and neuropathic pain matrices: a review. Pain 2013: S29–S43.
Wager TD, Atlas LY, Lindquist MA, et al. An fMRI-based neurologic signature of physical pain. N Engl J Med 2013 ; 368 : 1388–1397.
Fründt O, Grashorn W, Schöttle D, et al. Quantitative sensory testing in adults with autism spectrum disorders. J Autism Dev Disord 2017 ; 47 : 1183–1192.
De Jonckheere J, Bonhomme V, Jeanne M, et al. Physiological signal processing for individualized anti-nociception management during general anesthesia: a review. Yearbook Medical Informatics 2015 ; 10 : 95–101.
Ely E, Chen-Lim ML, Carpenter KM, et al. Pain assessment of children with autism spectrum disorders. J Dev Behav Pediatr 2016 ; 37 : 53–61.
Zabalia M, Breau LM, Wood C, et al. Validation francophone de la grille d’évaluation de la douleur-déficience intellectuelle: version postopératoire. Can J Anesth 2011 ; 58 : 1016–1023.
Dubois A, Michelon C, Rattaz C, et al. Daily living pain assessment in children with autism: Exploratory study. Res Dev Disabil 2017 ; 62 : 238–246.
Tordjman S, Anderson GM, Botbol M, et al. Pain reactivity and plasma β-endorphin in children and adolescents with autistic disorder. PLoS One 2009 ; 4 : e5289.
Cascio C, McGlone F, Folger S, et al. Tactile perception in adults with autism: a multidimensional psychophysical study. J Autism Dev Disord 2008 ; 38 : 127–137.
Yasuda Y, Hashimoto R, Nakae A, et al. Sensory cognitive abnormalities of pain in autism spectrum disorder: A case-control study. Ann Gen Psychiatry 2016 ; 15 : 8.
Vaughan S, McGlone F, Poole H, et al. A quantitative sensory testing approach to pain in autism spectrum disorders. J Autism Dev Disord 2019 ; 50 : 1607–1620.
Duerden EG, Taylor MJ, Lee M, et al. Decreased sensitivity to thermal stimuli in adolescents with autism spectrum disorder: relation to symptomatology and cognitive ability. J Pain 2015 ; 16 : 463–471.
Chien YL, Wu SW, Chu CP, et al. Attenuated contact heat-evoked potentials associated with sensory and social-emotional symptoms in individuals with autism spectrum disorder. Sci Rep 2017 ; 7 : 36887.
Failla MD, Moana-Filho EJ, Essick GK, et al. Initially intact neural responses to pain in autism are diminished during sustained pain. Autism 2018 ; 22 : 669–683.
Riquelme I, Hatem SM, Montoya P. Abnormal pressure pain, touch sensitivity, proprioception, and manual dexterity in children with autism spectrum disorders. Neural Plast 2016 ; 2016 : 1723401.
Fan YT, Chen C, Chen SC, et al. Empathic arousal and social understanding in individuals with autism: evidence from fMRI and ERP measurements. Soc Cogn Affect Neurosci 2014 ; 9 : 1203–1213.
Orefice LL. Peripheral somatosensory neuron dysfunction: emerging roles in autism spectrum disorders. Neuroscience 2020; 445 : 120–9.
Donovan APA, Basson MA. The neuroanatomy of autism: a developmental perspective. J Anatomy 2017 ; 230 : 4–15.
Riquelme I, Hatem SM, Montoya P. Reduction of pain sensitivity after somatosensory therapy in children with autism spectrum disorders. J Abnorm Child Psychol 2018 ; 46 : 1731–1740.
Orefice LL, Zimmerman AL, Chirila AM, et al. Peripheral mechanosensory neuron dysfunction underlies tactile and behavioral deficits in mouse models of ASDs. Cell 2016 ; 166 : 299–313.
Bhattacherjee A, Winter MK, Eggimann LS, et al. Motor, somatosensory, viscerosensory and metabolic impairments in a heterozygous female rat model of rett syndrome. Int J Mol Sci 2018 ; 19 : 97.
Das I, Estevez MA, Sarkar AA, et al. A multifaceted approach for analyzing complex phenotypic data in rodent models of autism. Mol Autism 2019 ; 10 : 11.
Song TJ, Lan XY, Wei MP, et al. Altered behaviors and impaired synaptic function in a novel rat model with a complete Shank3 deletion. Front Cell Neurosci 2019 ; 13 : 111.
Schneider T, Przewłocki R. Behavioral alterations in rats prenatally to valproic acid: animal model of autism. Neuropsychopharmacology 2005 ; 30 : 80–89.
Castro K, Baronio D, Perry IS, et al. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid. Nutr Neurosci 2017 ; 20 : 343–350.
Bossu JL, Roux S. Les modèles animaux d’étude de l’autisme : le modèle valproate. Med Sci 2019 ; 35 : 236–243.
Wang L, Almeida LEF, Nettleton M, et al. Altered nocifensive behavior in animal models of autism spectrum disorder: The role of the nicotinic cholinergic system. Neuropharmacology 2016 ; 111 : 323–334.
Wu HF, Chen PS, Chen YJ, et al. Alleviation of N-methyl-d-aspartate receptor-dependent long-term depression via regulation of the glycogen synthase kinase-3β pathway in the amygdala of a valproic acid-induced animal model of autism. Mol Neurobiol 2017 ; 54 : 5264–5276.
Mohammadi S, Asadi-Shekaari M, Basiri M, et al. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function. Psychopharmacology 2020; 237 : 199–208.
Baronio D, Castro K, Gonchoroski T, et al. Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid. PLoS One 2015 ; 10 : e0116363.
Ko HG, Oh SB, Zhuo M, et al. Reduced acute nociception and chronic pain in Shank2
Yoon SY, Kwon SG, Kim YH, et al. A critical role of spinal Shank2 proteins in NMDA-induced pain hypersensitivity. Mol Pain 2017 ; 13 : 1–9.
Nakajima R, Takao K, Hattori S, et al. Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice. Neuropsychopharmacol Reports 2019 ; 39 : 223–237.
Bhattacherjee A, Mu Y, Winter MK, et al. Neuronal cytoskeletal gene dysregulation and mechanical hypersensitivity in a rat model of Rett syndrome. Proc Natl Acad Sci USA 2017 ; 114 : E6952–E6961.
Han Q, Kim YH, Wang X, et al. SHANK3 deficiency impairs heat hyperalgesia and trpv1 signaling in primary sensory neurons. Neuron 2016 ; 92 : 1279–1293.
Price TJ, Rashid MH, Millecamps M, et al. Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR. J Neurosci 2007 ; 27 : 13958–13967.
Orefice LL, Mosko JR, Morency DT, et al. Targeting peripheral somatosensory neurons to improve tactile-related phenotypes in ASD models. Cell 2019 ; 178 : 867–886.
He Q, Arroyo ED, Smukowski SN, et al. Critical period inhibition of NKCC1 rectifies synapse plasticity in the somatosensory cortex and restores adult tactile response maps in fragile X mice. Mol Psychiatry 2019 ; 24 : 1732–1747.
Bird G, Silani G, Brindley R, et al. Empathic brain responses in insula are modulated by levels of alexithymia but not autism. Brain 2010 ; 133 : 1515–1525.
DeLorey TM, Sahbaie P, Hashemi E, et al. Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3. Behav Brain Res 2011 ; 216 : 36–45.

Auteurs

Lucien Ruelle-Le Glaunec (L)

CNRS, 5 rue Blaise-Pascal, 67000 Strasbourg, France - Université de Strasbourg, Institut des neurosciences cellulaires et intégratives, UPR 3212, 8 allée du Général Rouvillois, F-67000 Strasbourg, France.

Perrine Inquimbert (P)

CNRS, 5 rue Blaise-Pascal, 67000 Strasbourg, France - Université de Strasbourg, Institut des neurosciences cellulaires et intégratives, UPR 3212, 8 allée du Général Rouvillois, F-67000 Strasbourg, France.

Sylvain Hugel (S)

CNRS, 5 rue Blaise-Pascal, 67000 Strasbourg, France.

Rémy Schlichter (R)

CNRS, 5 rue Blaise-Pascal, 67000 Strasbourg, France - Université de Strasbourg, Institut des neurosciences cellulaires et intégratives, UPR 3212, 8 allée du Général Rouvillois, F-67000 Strasbourg, France.

Jean-Louis Bossu (JL)

CNRS, 5 rue Blaise-Pascal, 67000 Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH